Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 7 of 7
Full-Text Articles in Medicine and Health Sciences
Mifepristone Utilization In Cushing’S From Large Bilateral Adrenal Adenoma Prior To Surgery, Vasudev Magaji, Sarah Park, Katie Mastoris, Maura Bucciarelli, Scott Beman
Mifepristone Utilization In Cushing’S From Large Bilateral Adrenal Adenoma Prior To Surgery, Vasudev Magaji, Sarah Park, Katie Mastoris, Maura Bucciarelli, Scott Beman
Vasudev G Magaji MD, MS
Utilization of mifepristone was described to mitigate hypercortisolism from bilateral adrenal Cushing’s syndrome. A 47-year-old female on abdominal pain evaluation with CT was found to have a 5.4 × 1.7 × 4.9 cm right adrenal nodule and a 4.3 × 2.9 × 3.3 cm left adrenal nodule with calcification on CT scan with each having density of -3 Housefield units. She had hypercortisolism with testing revealing high urine free cortisol, unsuppressed cortisol on 1 mg and 8 mg overnight dexamethasone suppression testing, high 11 pm salivary cortisol × 2 along with elevated random cortisol and undetectable ACTH. Her DHEA-S, plasma …
Use Of An Electronic Medical Record (Emr) To Identify Glycemic Intensification Strategies In Type 2 Diabetes., Mary T Korytkowski, Maria Brooks, Manuel Lombardero, Dilhari Dealmeida, Justin Kanter, Vasudev Magaji, Trevor Orchard, Linda Siminerio
Use Of An Electronic Medical Record (Emr) To Identify Glycemic Intensification Strategies In Type 2 Diabetes., Mary T Korytkowski, Maria Brooks, Manuel Lombardero, Dilhari Dealmeida, Justin Kanter, Vasudev Magaji, Trevor Orchard, Linda Siminerio
Vasudev G Magaji MD, MS
Current treatment guidelines for type 2 diabetes (T2D) recommend individualized intensification of therapy for glycated hemoglobin (A1C) ≥ 7% in most patients. The purpose of this investigation was to explore the ability of an electronic medical record (EMR) to identify glycemic intensification strategies among T2D patients receiving pharmacologic therapy. Patient records between 2005 and 2011 with documentation of A1C and active prescriptions for any diabetes medications were queried to identify potential candidates for intensification based on A1C ≥ 7% while on 1-2 oral diabetes medications (ODM). Patients with follow-up A1C values within 1 year of index A1C were grouped according …
1,25-Dihydroxyvitamin D-Mediated Hypercalcemia In A Patient With Maligancy Without Lymphoma, Katie Mastoris, Sarah Park, Vasudev Magaji
1,25-Dihydroxyvitamin D-Mediated Hypercalcemia In A Patient With Maligancy Without Lymphoma, Katie Mastoris, Sarah Park, Vasudev Magaji
Vasudev G Magaji MD, MS
No abstract provided.
Comparison Of Insulin Infusion Protocols Targeting 110-140 Mg/Dl In Patients After Cardiac Surgery., Vasudev Magaji, Shriddha Nayak, Amy Donihi, Lauren Willard, Srinivasa Jampana, Parachur Nivedita, Raymond Eder, Jann Johnston, Mary Korytkowski
Comparison Of Insulin Infusion Protocols Targeting 110-140 Mg/Dl In Patients After Cardiac Surgery., Vasudev Magaji, Shriddha Nayak, Amy Donihi, Lauren Willard, Srinivasa Jampana, Parachur Nivedita, Raymond Eder, Jann Johnston, Mary Korytkowski
Vasudev G Magaji MD, MS
BACKGROUND: Continuous intravenous insulin infusion (CII) following coronary artery bypass graft (CABG) surgery reduces postoperative complications and hospitalization duration. Because of limited data evaluating outcomes of CII with revised glycemic targets (110-140 mg/dL) in cardiac surgery, this study compared efficacy and safety of two different CII protocols having revised targets. SUBJECTS AND METHODS: This is a retrospective study comparing two different protocols between August 2009 and March 2010. Protocol 1 consists of four algorithms, and Protocol 2 is a table to adjust CII. Blood glucose (BG) and CII rates were recorded for 48 h postoperatively or CII discontinuation. Efficacy was …
Efficacy And Safety Of Continuous Insulin Infusion Protocols With Glycemic Targets Of 110-140 Mg/Dl In Patients With And Without Diabetes Following Cardiac Surgery, Shriddha Nayak, Vasudev Magaji, Amy Donihi, Lauren Willard, Srinivasa Jampana, Parachur Nivedita, Raymond Eder, Jann Johnston, Mary Korytkowski
Efficacy And Safety Of Continuous Insulin Infusion Protocols With Glycemic Targets Of 110-140 Mg/Dl In Patients With And Without Diabetes Following Cardiac Surgery, Shriddha Nayak, Vasudev Magaji, Amy Donihi, Lauren Willard, Srinivasa Jampana, Parachur Nivedita, Raymond Eder, Jann Johnston, Mary Korytkowski
Vasudev G Magaji MD, MS
No abstract provided.
Inpatient Management Of Hyerglycemia And Diabetes, Vasudev Magaji, Jann Johnston
Inpatient Management Of Hyerglycemia And Diabetes, Vasudev Magaji, Jann Johnston
Vasudev G Magaji MD, MS
No abstract provided.
Short Term Unblinded Continuous Glucose Monitoring For Long Term Glucose Control, Vasudev Magaji, Adam Akers, Jann Johnston
Short Term Unblinded Continuous Glucose Monitoring For Long Term Glucose Control, Vasudev Magaji, Adam Akers, Jann Johnston
Vasudev G Magaji MD, MS
No abstract provided.